JCR 2024 Program
-
14. JCR-PMI
Room A : 08:00~09:00
-
31. Live Session 1
Room A : 09:00~10:30
-
15. JCR-DCB
Room A : 11:00~12:20
-
38. Sponsored Scientific Luncheon: LDL-C Lowering with PCSK9 Inhibitors: From Acute to Lifelong Management in ACS (Sponsored by Amgen)
Room A : 12:30~13:30
-
32. Live Session 2
Room A : 13:30~15:00
-
16. Complex PCI 1: Hot Topics in Complex PCI 2024
Room A : 15:20~16:50
14. JCR-PMI
Room A : 08:00~09:00
Chair
Bon-Kwon Koo, Hiromasa Otake, Eun-Seok ShinPanel
Sungjoon Park, Ae-Young Her, Sunwon Kim, Dong Oh Kang, Jinlong Zhang, Young-Hyo Lim, Ki Hong ChoiSpeaker
08:00-08:10 |
Morpho-functional approaches for CAD
Hiromasa Otake |
08:10-08:20 |
AI and image-based physiology for CAD assessment
Kwan Yong Lee |
08:20-08:30 |
Physiology-guided DCB treatment
Sodam Jung |
08:30-08:40 |
Time-dependent risk assessment for ACS
Seokhun Yang |
08:40-08:50 |
Association between Perivascular Adipose Tissue Attenuation and Outcomes after Endovascular Aortic Repair
Koshi Matsuhama |
31. Live Session 1
Room A : 09:00~10:30
Chair
Myung Ho Jeong, Jang Ho BaePanel
Woohyung Bae, Minwoong Kim, Chang-Bae Sohn, Chen Ting Tan, Katsuyuki Hasegawa, Jong-Il Park, Young Jin YounOperator
09:00-09:30 |
Live 1(Kosin University Gospel Hospital)
Jung Ho Heo |
09:00-09:30 |
Live 1(Kosin University Gospel Hospital)
Soo-Jin Kim |
09:00-09:30 |
Live 2(Kosin University Gospel Hospital)
Tae-Hyun Yang |
09:00-09:30 |
Live 2(Kosin University Gospel Hospital)
Han-Su Park |
Speaker
09:30-09:45 |
Bifurcation treatment using OCT
Yoichi Nozaki |
09:45-10:00 |
Respect the nature of the vessel-Nothing Behind theory may preserve vessel ability; DCA/DCB
Sunao Nakamura |
15. JCR-DCB
Room A : 11:00~12:20
Chair
Bon-Kwon Koo, Eun-Seok Shin, Shiro OnoPanel
Chang-Wook Nam, Joon Hyung Doh, Eun Ho Choo, Seokhun Yang, Jong Seok LeeSpeaker
11:00-11:12 |
Serial functional change after balloon angioplasty and post-procedure
Sodam Jung |
11:12-11:24 |
Clinical impact of DCB treatment in ACS patients
Masaaki Okutsu |
11:24-11:36 |
DCB treatment for de novo CAD in patients with high-bleeding risk
Ae-Young Her |
11:36-11:48 |
The role of DCB treatment in large vessel CAD
Dong Oh Kang |
11:48-12:00 |
Predictors of angiographic outcomes after DCB treatment for de novo CAD
Sunwon Kim |
38. Sponsored Scientific Luncheon: LDL-C Lowering with PCSK9 Inhibitors: From Acute to Lifelong Management in ACS (Sponsored by Amgen)
Room A : 12:30~13:30
Chair
Moo Hyun Kim, Cheol Woong YuPanel
Hong Nyun Kim, Hyunsu Kim, Yong Hwan Park, Tae-Hyun Yang, Seong Yoon Jeong, Jeong Cheon ChoeSpeaker
12:30-12:50 |
Why Choose Evolocumab for ASCVD: Clinical Benefits for Patients
Robert Patrick Giugliano |
12:50-13:10 |
How to Use PCSK9 inhibitor for ACS: Practical Benefits for Patients
Dong Oh Kang |
32. Live Session 2
Room A : 13:30~15:00
Chair
Hee-Yeol Kim, Astunori Okamura, Jun-Jie ZhangPanel
Janghoon Lee, Masaaki Okutsu, Hiromasa Otake, Yoichi Nozaki, Katsuyuki Hasegawa, Sang Ho ParkOperator
13:30-14:00 |
Live Case 3(Kosin University Gospel Hospital)
Kook-Jin Chun |
13:30-14:00 |
Live Case 3(Kosin University Gospel Hospital)
Jung Ho Heo |
13:30-14:00 |
Live Case 4(Kosin University Gospel Hospital)
Hun Sik Park |
13:30-14:00 |
Live Case 4(Kosin University Gospel Hospital)
Han-Su Park |
Speaker
14:00-14:15 |
Tips and tricks about TD-ADR in CTO PCI
Astunori Okamura |
14:15-14:30 |
Current situation of ECG synchronization
Katsuyuki Hasegawa |
16. Complex PCI 1: Hot Topics in Complex PCI 2024
Room A : 15:20~16:50
Chair
In-Ho Chae, Bill D. Gogas, Seung-Woon RhaPanel
Jae Sik Jang, Sang Ho Park, Dong Oh Kang, Janghoon Lee, Gianluca Rigatelli, Kyusup LeeSpeaker
15:20-15:35 |
Complications of mechanical circulatory support
Erin Bohula |
15:35-15:50 |
Heavily calcified lesion as hard as a rock: stent or DCB?
Sung-Ho Her |
15:00-16:05 |
Revascularization for Left Main Disease: where do we stand?
Duk-Woo Park |
16:05-20 |
LM PCI: 1 vs 2 stents
Bill D. Gogas |